Notably, the expression of Lgr5 is reported to be increased in human colorectal adenomas and cancers [104–106], hepatocellular carcinoma, basal cell carcinoma, and neuroblastoma [55, 107, 108]. Here, LGR5 is linked to basal cell carcinoma.